Medicina
Departamento
Loreto
Carmona Ortells
Publicaciones en las que colabora con Loreto Carmona Ortells (25)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2021
-
Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey
Joint Bone Spine, Vol. 88, Núm. 4
2020
-
Practical Aspects of Biological Throught Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis
Reumatologia Clinica, Vol. 16, Núm. 5, pp. 378-385
2019
-
Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs
Rheumatology International, Vol. 39, Núm. 6, pp. 1077-1082
-
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
RMD Open, Vol. 5, Núm. 2
2018
-
Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (Rheumatology International, (2018), 38, 9, (1735-1740), 10.1007/s00296-018-4097-y)
Rheumatology International
-
Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review
Rheumatology International, Vol. 38, Núm. 6, pp. 975-983
-
The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern
Rheumatology International, Vol. 38, Núm. 9, pp. 1735-1740
-
Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence
Rheumatology International, Vol. 38, Núm. 12, pp. 2289-2296
2017
-
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155
-
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study
Rheumatology International, Vol. 37, Núm. 7, pp. 1195-1202
-
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study
Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430
-
The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3
Advances in Therapy
-
Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies
Annals of the Rheumatic Diseases, Vol. 76, Núm. 11, pp. 1870-1882
2016
-
Epidemiology and health-related services
Current Opinion in Rheumatology, Vol. 28, Núm. 2, pp. 104-109
2015
-
Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)
Rheumatology International
-
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137
2014
-
The burden of disease in Spain: Results from the global burden of disease study 2010
BMC Medicine, Vol. 12, Núm. 1
-
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 177-182
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223